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Abstract
Background: Probable migraine (PM) is a subtype of migraine that is prevalent in the general population. Previous
studies have shown that poor sleep quality is common among migraineurs and is associated with an exacerbation
of migraine symptoms. However, information on the prevalence and clinical implication of poor sleep quality
among individuals with PM is scarce. Thus, the aim of this study was to assess the prevalence and clinical impact of
poor sleep quality in individuals with PM in comparison with those with migraine.
Methods: Two-stage cluster random sampling was used to perform the survey for sleep and headache in Korean
general population. Participants with Pittsburgh Sleep Quality Index > 5 were considered as having poor sleep
quality.
Results: Of 2695 participants, 379 (14.1%) had PM and 715 (26.5%) had poor sleep quality. Prevalence of poor sleep
quality was 35.4% in the PM group, which was lower than that in the migraine group (47.6%, p = 0.011), but higher
than that in the non-headache group (21.4%, p < 0.001). The PM participants with poor sleep quality showed
increased headache frequency (median [interquartile range]: 2.0 [0.3–4.0] vs. 1.0 [0.2–2.0]; p = 0.001) and headache
intensity (visual analogue scale, 6.0 [4.0–7.0] vs. 5.0 [3.5–6.0]; p = 0.003) compared to PM participants who had no
poor sleep quality.
Conclusions: Poor sleep quality was prevalent among participants with PM. It was associated with an exacerbation
of PM symptoms. Our findings suggest that proper evaluation and treatment for poor sleep quality are needed in
the management of PM.
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Background
Probable migraine (PM) is classified when one of diag-
nostic criteria of migraine in the third edition of the
international classification of headache disorders
(ICHD-3) is not applicable [1]. Probable migraine affects
approximately 5–10% of the general population. It
causes significant amount of disability owing to its
symptoms such as migraine [2–4]. Although previous
studies have demonstrated that patients with PM have
relatively milder headache symptoms compared to indi-
viduals with migraine [3, 5], many patients with PM ex-
perience poor quality of life related to health with
considerable disability [4].
Previous researches have revealed that sleep distur-
bances are frequent among migraineurs. Accompanying
insomnia is more frequently noted in migraineurs than
that in non-migraineurs [6]. Additionally, excessive day-
time sleepiness is more prevalent among migraineurs. It
is associated with worsening migraine symptoms [7].
Habitual snoring and bruxism are known to be risk fac-
tors of chronic migraine, a chronic form of migraine
showing more severe symptoms and more frequent co-
morbidities compared to episodic migraine [8, 9]. Rest-
less legs syndrome is also significantly associated with
migraine [10].
Both sleep quantity and quality are important not only
for health, but also for well-being [11]. Sleep studies
have demonstrated that duration of sleep does not differ
between non-migraineurs and migraineurs [12, 13].
Therefore, difference in sleep quality may explain the
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higher sleep disturbance in migraineurs. Several studies
have shown that poor sleep quality in migraineurs is
more frequently noted compared to that in
non-migraine individuals with headache [14, 15]. More-
over, migraineurs who had poor sleep quality showed
more frequent headache as well as symptoms of depres-
sion and anxiety [16].
Although PM is a common headache disorder, infor-
mation about prevalence and clinical impact of poor
sleep quality in individuals with PM is limited. We hy-
pothesized that poor sleep quality would be prevalent in
participants with PM and that it would be associated
with an aggravation of clinical presentation of PM, as in
the case with migraine. The Korean Headache-Sleep
Study (KHSS) is a nationwide, general population-based
survey about headache and sleep. The KHSS may give us
a chance to investigate the relationship of PM with poor
sleep quality. Thus, the aim of this study was to evaluate
the prevalence and impact of poor sleep quality among
participants with PM and those with migraine using data
of the KHSS. Factors associated with poor sleep quality
in participants with PM were also assessed.
Methods
Survey
KHSS is a nation-wide and cross-sectional study regard-
ing headache and sleep characteristics among adult (19–
69 years old) across Korean general population. Detailed
protocol and methods of KHSS were described else-
where [17]. Briefly, KHSS used two-stage random sam-
pling methods. The study population of KHSS was based
on the distribution of Korean population except
Jeju-island [17]. To prevent interest bias, we informed
all participants that our survey theme was a social health
issue than neurological disorders such as headache and
sleep problems. The survey was conducted by
door-to-door visits and face-to-face interviews, using a
structured questionnaire. The questionnaire covered in-
formation regarding characteristics of headache, sleep,
anxiety, and depression. All interviewers were not med-
ical related workers. They were members of Gallup
Korea. The KHSS was approved by the Institutional Re-
view Board of Hallym University Sacred Heart Hospital
(approval No. 2011-I077). We received written consent
from all participants before the survey interview. The
survey was performed from November 2011 to January
2012.
Diagnosis of migraine and PM
Migraine and PM were diagnosed based on ICHD-2
diagnostic criteria which was valid at that time [18]. Mi-
graine was defined based on code 1.1 migraine without
aura of ICHD-2 [18]. If a participant satisfied A, B, C,
and D criteria of 1.1 migraine without aura, she/he was
classified as having migraine. If one of criteria for mi-
graine was not satisfied, the participant was classified as
having PM. It is difficult to define code 1.2.1 migraine
with aura or code 1.6.2 PM with aura in epidemiological
study using questionnaire survey methods [19]. There-
fore, our study did not estimate the presence of aura.
Our study’s migraine included both code 1.1 migraine
without aura and code 1.2 migraine with aura [18] while
PM included both code 1.6.1 PM without aura and code
1.6.2 PM with aura [18]. Our study questionnaire exhib-
ited a sensitivity of 75.0% and a specificity of 88.2% in
migraine diagnosis compared to doctor’s diagnosis via
telephone interview and result in the survey [20]. Fre-
quency of headache per month, visual analogue scale
(VAS) for headache intensity, and Headache Impact
Test-6 (HIT-6) for impact of headache was investigated.
Non-headache participants were defined as those who
reported no headache during the previous year.
Poor sleep quality, anxiety, and depression
Pittsburgh Sleep Quality Index (PSQI) was applied to as-
sess sleep quality. Participants with total PSQI score > 5
were defined as having poor sleep quality [21]. We also
investigated each component score of PSQI such as sub-
jective quality of sleep, latency of sleep, duration of
sleep, habitual sleep insufficiency, disturbance of sleep,
use of hypnotics, and dysfunction at daytime [21]. Gold-
berg Anxiety Scale was used for the diagnosis of anxiety.
The Goldberg Anxiety Scale includes four screening
items and five supplementary items [22, 23]. Participants
who presented positive answers with more than two of
screening items or with more than five of all scale items
were classified as persons with anxiety. The Korean ver-
sion of Goldberg Anxiety Scale was validated in previous
studies, with a sensitivity of 82.0% and a specificity of
94.4% [23, 24]. Patient Health Questionnaire-9 (PHQ-9)
was applied to investigate the presence of depression
[25]. In this scoring system, presence of depression was
defined as 10 points or more. The Korean version of
PHQ-9 was also validated with a sensitivity of 81.1% and
a specificity of 89.9% [26].
Statistical analyses
All statistical analyses were performed using SPSS 22.0
(IBM, Armonk, NY, USA). Kolmogorov-Smirnov test
was used to check normal distribution for continuous
variables. If variables showed normal distribution, inde-
pendent t-test or one-way analysis of variance was used.
If variables did not show normal distribution,
Mann-Whitney U-test or Kruskal-Wallis test was per-
formed. Categorical variables were analysed using
Chi-square test or Fisher’s exact test. We used Mann
−Whitney U-test to compare headache frequency per
month, VAS score for headache intensity, and HIT-6
Song et al. The Journal of Headache and Pain  (2018) 19:58 Page 2 of 8
score between participants had PM with and without
poor sleep quality.
For assessing factors contributing to poor sleep quality
among participants with PM, we performed multivariable
linear regression analyses after adjusting sociodemo-
graphic variables (age, sex, residential area size, and level
of education), GAS score for anxiety, PHQ-9 score for de-
pression, frequency of headache (per month), and inten-
sity of headache (VAS score). Statistical significance was
considered when p value (two-tailed) was less than 0.05.
Results
Survey
We interviewed 7430 people and 3114 people who
agreed to participate in our study (58.1% of rejection
rate). Of these, 419 people withdraw participation during
the interview. Finally, 2695 people completed our survey
(36.3% of cooperation rate, Fig. 1). Distribution of sex,
age, residence size, or education level of our sample was
not significantly different from that in the general popu-
lation in Korea (Table 1).
Prevalence of migraine and PM
Of 2695 subjects included in our study, 1273 (47.2%)
had at least one headache over the past year, including
143 (5.3%) migraineurs and 379 (14.1%) who had PM.
Seven hundred and fifteen (26.5%) participants had poor
sleep quality (Table 1). The prevalence of PM was the
highest (16.8%) in 30–39 and 40–49 age groups. Of
379 PM participants, 339 (89.5%), 29 (7.7%), and 11
(2.8%) missed criterion B (typical duration of headache),
criterion C (typical headache characteristics), and
criterion D (typical accompanying symptoms) of code
1.1 migraine diagnostic criteria, respectively.
Prevalence of poor sleep quality and comparison of PSQI
score according to headache diagnosis
The prevalence of poor sleep quality was significantly
higher in participants with PM (35.4%) than that in par-
ticipants with non-headache (21.0%, p < 0.001), but lower
than that in participants with migraine (47.6%, p =
0.011). Regarding PSQI, component scores for latency of
sleep (mean ± standard deviation) (1.1 ± 1.0 vs. 0.8 ± 0.9,
p = 0.001), sleep duration (0.6 ± 0.8 vs. 0.4 ± 0.8, p =
0.001), sleep disturbance (0.9 ± 0.6 vs. 0.8 ± 0.5, p =
0.001), use of sleeping medication (0.1 ± 0.4 vs. 0.0 ± 0.2,
p = 0.001), daytime dysfunction (0.8 ± 0.7 vs. 0.5 ± 0.6, p
= 0.001), and total score (5.2 ± 2.4 vs. 4.2 ± 1.9, p = 0.001)
were higher in PM participants than those in
non-headache participants. However, PSQI component
scores for subjective sleep quality (1.7 ± 0.7 vs. 1.7 ± 0.8,
p = 0.879) and habitual sleep efficacy (0.0 ± 0.3 vs. 0.0 ±
1.5, p = 0.119) did not significantly differ between PM
and non-headache participants. When comparing PM
participants with migraineurs, PSQI component scores
for sleep latency and sleep disturbance as well as total
PSQI score were higher in participants with migraine
than those in participants with PM (Table 2).
Clinical presentations of PM according to presence of
poor sleep quality
Participants with PM combined with poor sleep quality
had higher proportion of anxiety (p < 0.001), depression
(p < 0.001), and frequency of headache attack (median
[interquartile range]: 2.0 [0.3–4.0] vs. 1.0 [0.2–2.0], p =
Fig. 1 Flowchart depicting enrolment and participation in the Korean Headache-Sleep Study
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0.001) as well as higher headache intensity (VAS score,
6.0 [4.0–7.0] vs. 5.0 [3.5–6.0], p = 0.003) and higher
HIT-6 score (50.0 [44.0–58.0] vs. 44.0 [40.0–50.0], p =
0.001) compared to participants with PM not combined
with poor sleep quality (Table 3). Participants with
migraine who combined with poor sleep quality had
higher proportion of anxiety, depression, frequency of
headache attack and higher HIT-6 score compared to
participants with migraine who not combined with poor
sleep quality (Table 3).
Table 1 Sociodemographic characteristics of survey participants, the total Korean population, and cases identified as having
migraine, probable migraine, and poor sleep quality
Characteristic Survey participants
N (%)
Total population
N (%)
p Migraine N, %
(95% CI)
Probable migraine N, %
(95% CI)
Poor sleep quality N, % (95% CI)
(PSQI > 5)
Sex
Male 1345 (49.3) 17,584,365 (50.6) 0.854a 36, 2.7 (1.8−3.5) 136, 10.1 (8.5−11.8) 334, 24.8 (22.5−27.1)
Female 1350 (50.7) 17,198,350 (49.4) 107, 7.9 (6.5−9.4) 243, 17.9 (15.8−19.9) 381, 28.2 (25.8−30.6
Age, years
19–29 542 (20.5) 7,717,947 (22.2) 0.917a 25, 4.5 (2.7−6.2) 69, 12.6 (9.8−15.4) 153, 28.3 (24.4−32.0)
30–39 604 (21.9) 8,349,487 (24.0) 42, 7.0 (4.9−9.1) 102, 16.8 (13.7−19.8) 136, 22.5 (19.2−25.9)
40–49 611 (23.1) 8,613,110 (24.8) 39, 6.5 (4.5−8.4) 102, 16.8 (13.9−19.8) 167, 27.3 (23.8−30.1)
50–59 529 (18.9) 6,167,505 (17.7) 22, 4.1 (2.4−5.9) 62, 11.6 (8.8−14.4) 160, 30.2 (26.3−34.2)
60–69 409 (15.6) 3,934,666 (11.3) 15, 3.9 (2.0−5.7) 44, 11.2 (8.1−14.2) 99, 24.2 (20.0−28.4)
Size of the residential area
Large city 1248 (46.3) 16,776,771 (48.2) 0.921a 76, 6.1 (4.8−7.5) 180, 14.4 (12.4−16.3) 338, 27.1 (24.6−30.0)
Medium-to-
small city
1186 (44.0) 15,164,345 (43.6) 48, 4.0 (2.9−5.2) 174, 14.7 (12.7−16.7) 303, 25.5 (23.1−28.0)
Rural area 261 (9.7) 2,841,599 (8.2) 19, 7.4 (4.2−10.6) 25, 9.7 (6.1−13.3) 74, 28.4 (22.8−33.9)
Education level
Middle school
or less
393 (14.9) 6,608,716 (19.0) 0.752a 22, 5.5 (4.2−7.7) 44, 11.5 (8.4−14.7) 110, 28.0 (23.5−32.4)
High school 1208 (44.5) 15,234,829 (43.8) 60, 5.0 (3.8−6.3) 178, 14.7 (12.7−16.7) 317, 26.2 (24.0−28.7)
College or
more
1068 (39.6) 12,939,170 (37.2) 60, 5.6 (4.3−7.0) 155, 14.4 (12.3−16.5) 281, 26.3 (23.7−29.0)
Did not
respond
26 (9.6) 1, 3.8 (0.0−11.8) 2, 7.7 (0.0−18.7) 7, 26.9 (8.7−45.2)
Total 2695 (100.0) 34,782,715 (100.0) 143, 5.3 (4.5−6.2) 379, 14.1 (12.7−15.4) 715, 26.5 (24.8−28.2)
N number, CI confidence interval, PSQI Pittsburgh Sleep Quality Index
aCompared with corresponding value reported in the general population of Korea
Table 2 Total and subcomponent PSQI scores among participants with no headache, probable migraine, and migraine
Component Non-headache N = 1422 Probable migraine N = 379 Migraine N = 143 p value
Subjective sleep quality 1.7 ± 0.8 1.7 ± 0.7 1.7 ± 0.7 0.609
Sleep latency 0.8 ± 0.9 1.0 ± 1.0* 1.3 ± 1.1†‡ < 0.001
Sleep duration 0.4 ± 0.8 0.6 ± 0.8* 0.5 ± 0.8†‡ 0.001
Habitual sleep efficacy 0.0 ± 1.5 0.0 ± 0.3 0.0 ± 0.0 0.116
Sleep disturbance 0.8 ± 0.6 0.9 ± 0.6* 1.1 ± 0.6†‡ < 0.001
Use of sleeping medication 0.0 ± 0.3 0.1 ± 0.4* 0.1 ± 0.5† 0.001
Daytime functioning 0.5 ± 0.7 0.8 ± 0.7* 0.9 ± 0.9†‡ < 0.001
Total 4.2 ± 1.9 5.2 ± 2.4* 5.6 ± 2.6†‡ < 0.001
PSQI Pittsburgh Sleep Quality Index
Data are presented as mean ± standard deviation
Each PSQI component score has a range of 0–3 points. Higher PSQI score indicates more severe disability
*p < 0.05 for non-headache vs. probable migraine, by Tukey’s post-hoc analysis
†p < 0.05 for non-headache vs. migraine, by Tukey’s post-hoc analysis
‡p < 0.05 for probable migraine vs. migraine, by Tukey’s post-hoc analysis
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Table 3 Demographics and clinical presentations of participants with migraine and probable migraine stratified according to the
presence of poor sleep quality
Characteristic Migraine with poor sleep
quality N = 68 (47.5%)
Migraine without poor sleep
quality N = 75 (52.5%)
p
value
PM with poor sleep
quality N = 134 (35.3%)
PM without poor sleep
quality N = 245 (64.7%)
p
value
Demographics
Age, years 41.9 ± 13.0 40.6 ± 11.9 0.546 40.8 ± 13.0 42.5 ± 12.4 0.217
Female 51 (75.0) 56 (74.7) 0.963 86 (64.2) 157 (64.1) 0.985
Headache characteristics
Bilateral pain 36 (52.9) 45 (60.0) 0.395 73 (54.5) 148 (60.4) 0.263
Non-pulsating
quality
46 (67.6) 62 (82.7) 0.037 110 (82.1) 200 (81.6) 0.912
Mild-to-
moderate
severity
58 (85.3) 57 (76.0) 0.162 12 (9.0) 8 (3.3) 0.018
Not aggravated
by movement
48 (70.6) 52 (69.3) 0.870 85 (63.4) 151 (61.6) 0.730
Accompanying symptoms
Nausea 59 (86.8) 66 (88.0) 0.824 117 (87.3) 20.7 (84.5) 0.456
Vomiting 27 (39.7) 28 (37.3) 0.771 47 (35.1) 68 (27.8) 0.138
Photophobia 41 (60.3) 43 (57.3) 0.719 70 (52.2) 110 (44.9) 0.171
Phonophobia 50 (73.5) 51 (68.0) 0.468 101 (75.4) 167 (68.2) 0.140
Osmophobia 35 (51.5) 33 (44.0) 0.372 71 (53.0) 108 (44.1) 0.097
Accompanying psychiatric problems
Anxiety (GAS
score≥ 5)
33 (48.5) 10 (13.3) <
0.001
43 (32.1) 24 (9.8) <
0.001
Depression
(PHQ-9 score≥
10)
19 (27.9) 5 (6.7) 0.001 28 (20.9) 5 (2.0) <
0.001
Headache
frequency
2.0 (1.0–7.0) 1.0 (1.0–5.0) 0.009 2.0 (0.3–4.0) 1.00 (0.3–2.0) 0.001
VAS score for
headache intensity
7.0 (4.0–10.0) 6.0 (4.0–8.0) 0.247 6.0 (4.0–7.0) 5.00 (3.5–6.0) 0.003
HIT-6 score 57.5 (50.0–65.0) 50.0 (43.0–57.0) <
0.001
50.0 (44.0–58.0) 44.0 (40.0–50.0) <
0.001
Data are presented as mean ± standard deviation, number (percent), or median (interquartile range)
PM probable migraine, GAS Goldberg Anxiety Scale, PHQ Patient Health Questionnaire, VAS visual analogue scale, HIT Headache Impact Test
Table 4 Analysisa of contributing factors related to the total PSQI score in participants with probable migraine
Factor Unstandardized coefficients Standardized coefficients T p
value
Tolerance VIF
B SE β
Age −0.086 0.085 −0.046 −1.019 0.309 0.810 1.235
Sex −0.177 0.202 −0.036 −0.877 0.381 0.969 1.032
Size of residential area −0.086 0.157 −0.022 − 0.548 0.584 0.988 1.012
Educational level −0.082 0.131 −0.028 −0.629 0.529 0.792 1.262
Anxiety (GAS score≥ 5) 0.231 0.052 0.230 4.438 < 0.001 0.602 1.660
Depression (PHQ-9 score≥ 10) 0.230 0.027 0.426 8.471 < 0.001 0.640 1.563
Headache frequency per month 0.039 0.018 0.090 2.166 0.031 0.928 1.077
VAS score for headache intensity 0.088 0.056 0.065 1.556 0.121 0.923 1.083
PSQI Pittsburgh Sleep Quality Index, SE standard error, VIF variation inflation factor, GAS Goldberg Anxiety Scale, PHQ Patient Health Questionnaire, VAS visual
analogue scale
Independent variables included sociodemographic variables (age, sex, size of residential areas, and education level), anxiety (GAS score ≥ 5), depression (PHQ-9
score ≥ 10), headache frequency per month, and VAS score for headache intensity, whereas total PSQI score was included as the dependent variable
amultivariate linear regression: R2 = 0.194, adjusted R2 = 0.139
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Factors associated with PSQI score among PM
participants
In multivariable linear regression analysis, anxiety (β =
0.230, p < 0.001), depression (β = 0.426, p < 0.001), and
headache frequency per month (β = 0.090, p = 0.031) were
significant independent factors associated with total PSQI
score in participants with PM (Table 4).
Discussion
The main findings of our research were as follows. First,
prevalence of migraine, PM, and poor sleep quality in
Korean general population were 5.3%, 14.1%, and 26.5%,
respectively. Second, 35.3% of participants with PM had
poor sleep quality, which was lower than the prevalence
noted in participants with migraine, but higher than that
in participants with non-headache. Third, among PM
participants, those with poor sleep quality showed in-
creased headache frequency, intensity, and impact.
Among migraineurs, poor sleep quality is not an un-
common problem. A clinic-based study in India has re-
ported that 66.7% of migraineurs without aura show
poor sleep quality. This proportion is higher than that in
non-migraine participants [14]. A Chinese study investi-
gating 1023 nurses has demonstrated that, compared to
tension-type headache or non-headache participants,
migraineurs have reported significantly higher frequency
of poor sleep quality [27]. In our study, the first to assess
the prevalence of poor sleep quality among individuals
with PM in a population-based setting, approximately
half of migraineurs and one-third of individuals with PM
experienced poor sleep quality. This confirms that poor
sleep quality is a common comorbidity not only in
migraineurs, but also in individuals with PM.
Among PSQI components, latency of sleep, duration
of sleep, sleep disturbance, hypnotics use, and daytime
dysfunction scores were significantly higher in partici-
pants with PM than those in non-headache participants.
This suggests that various aspects of sleep quality are
impaired in individuals with PM. One interesting finding
is the impairment of daytime functioning among partici-
pants with PM. Indeed, individuals with migraine or PM
often report disability even during interictal period [28].
Migraineurs are less physically active with reduced
vigour. They show higher levels of sleepiness and more
anxiety and avoidance [28]. Our findings are in line with
results of previous observation [28], additionally indicat-
ing that daytime dysfunction in PM patients might be
associated with poor sleep quality.
Our study demonstrated that anxiety, depression, and
headache frequency were associated with poor sleep
quality. This is in agreement with previous observations
showing that anxiety and depression are independently
related factors for PSQI score [29, 30] and that headache
frequency is positively associated with PSQI score
among migraineurs [31]. Our results confirmed that
anxiety, depression, and headache frequency were sig-
nificant factors for PSQI score among individuals with
PM.
Insomnia is a prevalent sleep disorder. Individuals with
insomnia may have difficulty falling asleep, staying
asleep or early awakening even if enough time is given
[32]. Poor sleep quality can occur as a result of insomnia
[33]. Nevertheless, it can be caused by other conditions
such as sleep apnea, shift working, use of medications,
environmental factors et al. [34–37]. Therefore, the poor
sleep quality is related to insomnia but measures border
sleep difficulties. We already investigated the association
of poor sleep quality and migraine in a population-based
sample [38]. Here, we firstly report the relationship of
poor sleep quality and PM, another common and disab-
ling headache disorder.
Based on findings of the present study, we propose the
following strategies to improve sleep quality in participants
with PM. Since anxiety, depression, and headache fre-
quency are independent factors associated with poor sleep
quality in individuals with PM, they could be successfully
managed by pharmacological and non-pharmacological
treatments. Anxiolytic drugs and antidepressants are effect-
ive in reducing anxiety and depression symptoms [39].
Non-pharmacological cognitive behaviour therapy (CBT)
can be used to treat anxiety and depression [40]. Headache
frequency can be reduced by preventive pharmacological
treatment and non-pharmacological treatments such as re-
laxation techniques, CBT, education, and mindfulness [41].
Therefore, pharmacological and non-pharmacological treat-
ments of anxiety, depression, and headache frequency
might be able to improve sleep quality of individuals with
PM. Such strategies may improve symptoms of PM by im-
proving sleep quality.
In the present study, PM participants with poor sleep
quality had more headache frequency and more severe
headaches than PM participants without poor sleep
quality. Considering that headache frequency and inten-
sity are closely associated with headache-related disabil-
ity and health-related quality of life, poor sleep quality
may be an important factor for such aspects in individ-
uals with PM [42]. Sleep quality may be improved using
pharmacological and non-pharmacological treatments
[43]. Our present findings suggest that, among individ-
uals with PM, proper assessment and treatment of poor
sleep quality may be needed to reduce headache-related
disability and improve quality of life besides improving
headache symptoms.
Our research has some limitations. First, although
questionnaire was utilized to the diagnosis of PM and
migraine, this questionnaire was only validated in mi-
graine, but not validated in PM. According to ICHD-2,
the diagnosis of PM is diagnosed only when one of the
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criteria of migraine is not satisfied. Thus, validation for
PM itself is not necessarily required. Second, we evalu-
ated sleep quality using a questionnaire without per-
forming actigraphy or polysomnography to confirm the
sleep quality objectively. Nevertheless, we found it not
only practical, but also appropriate to use PSQI because
this tool was validated for assessing sleep quality, show-
ing good agreement with polysomnography and actigra-
phy measurements [44]. Therefore, it has been widely
adopted in clinical and epidemiological studies. Third,
although our study was population-based with low sam-
pling error, its statistical power was limited because our
study could not preform subgroup analysis due to lim-
ited sample size. Lastly, we did not included medications
for migraine and PM treatment in analyses. Although a
significant proportion of migraineurs did not receive
medical treatment, some medications for acute and pre-
ventive treatments may influence on sleep quality. Caf-
feine, a common ingredient of acute migraine treatment,
may impair sleep quality [45]. Topiramate is a widely
used medication for preventive migraine treatment and
may induce dysphoria or unmask latent mood disorder
[46]. Further studies are needed the effect of migraine
medications on sleep quality among individuals of mi-
graine and PM.
On the other hand, the present study has several
strengths. First, our study used a questionnaire whose Ko-
rean version was specifically validated for assessing mi-
graine, anxiety, depression, and sleep quality. Second, we
applied clustered random sampling proportional to the
distribution in the Korean general population with low
sampling error which allowed us to accurately assess the
prevalence of migraine, PM, and poor sleep quality. Third,
we investigated PSQI component scores in addition to
total scores. PSQI comprises seven components including
subjective sleep quality, latency of sleep, duration of sleep,
habitual sleep efficacy, sleep disturbance, use of hypnotics,
and dysfunction at daytime. By investigating these various
aspects of sleep quality separately, we were able to deter-
mine that some components were impaired in participants
with PM.
Conclusion
Although the prevalence of poor sleep quality was lower
in participants with PM than that in migraineurs, preva-
lence remained high in those with PM. It was associated
with worse symptoms of PM. Our results suggest that ap-
propriate diagnostic approach and management of poor
sleep quality are necessary to manage PM appropriately.
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